Sort   by:  
 Page size 
UnknownOpen-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Not available
S-EPMC9673084 | biostudies-literature
UnknownMetallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease.
Not available
S-EPMC10532173 | biostudies-literature
UnknownRationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR).
Not available
S-EPMC6490432 | biostudies-literature
UnknownPredicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model.
Not available
S-EPMC8280376 | biostudies-literature
UnknownMultilevel mortality risk factors among pediatric hematology-oncology patients with deterioration.
Not available
S-EPMC11975202 | biostudies-literature
UnknownRationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial.
Not available
S-EPMC4425893 | biostudies-literature
UnknownImpact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Not available
S-EPMC11882944 | biostudies-literature
UnknownActive Surveillance of Antimicrobial Resistance and Carbapenemase-Encoding Genes According to Sites of Care and Age Groups in Mexico: Results from the INVIFAR Network.
Not available
S-EPMC10537696 | biostudies-literature
UnknownValidation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Not available
S-EPMC9862219 | biostudies-literature
UnknownEffect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.
Not available
S-EPMC10734790 | biostudies-literature
Sort   by:  
 Page size